April 19, 2012 — Spherix Inc. announced results from its recently completed studies using near-infrared spectroscopy on autopsy samples from humans who had confirmed cardiovascular disease. Results showed that these atherosclerotic plaques had abnormally high amounts of macrophages and reduced levels of collagen and elastin. Reducing collagen and elastin weakens the plaques and contributes to plaque rupture, myocardial infarction and/or stroke.

April 17, 2012 — Isansys Lifecare Ltd., provider of complete real-time physiological patient data services and systems, announced that it has achieved CE certification for its LifeTouch Patient Surveillance System, comprising the LifeTouch HRV011 intelligent body-worn wireless sensor and associated Patient Gateway. The LifeTouch is the world’s first cloud-ready medical device of its kind.

April 17, 2012 — St. Jude Medical Inc. announced the first implant in its Accent MRI Pacemaker and Tendril MRI Lead IDE Study. The ultimate goal of the study is to determine if patients with these devices can safely undergo full-body, high-resolution magnetic resonance imaging (MRI) scans to better accommodate their medical needs.


April 17, 2012 –– Expanding its commitment to developing innovative treatments for cardiovascular disease and the evidence to support their adoption, Medtronic announced the start of the Medtronic IN.PACT SFA II study, the company’s first U.S. clinical trial for its line of IN.PACT drug-eluting balloons.

April 17, 2012 — Radius LLC is expanding its unique pay-per-study RIS/PACS model to include the option of on-demand 3-D imaging reconstruction.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now